Standalone PBT stood at Rs.1.09 Crore in FY2018-19 as against Rs.31.5 Lakh in previous year, at Vanta Bioscience

Company : Vivid Mercantile Ltd

Vanta Bioscience Ltd earned standalone revenue of Rs.12.65 Crore and consolidated revenue reached Rs.12.71 Crore in FY2018-19 whereas in previous year it was at Rs.4.03 Crore.

Following are the detailed standalone financial facts of Vanta Bioscience Ltd:

- PBT was Rs.63.93 Lakh in HY31.3.2019 whereas in previous year it was Rs.25.21 Lakh.
- PAT was Rs.40.08 Lakh in HY31.3.2019 whereas in last year it was net loss of Rs.2.36 Lakh.
- In the FY2018-19 PAT reached Rs.69.38 Lakh as compared to last year's annual net profit of Rs.2.73 Lakh.

Consolidated data are as followed:

- PBT was Rs.64.29 Lakh and PAT was Rs.40.35 Lakh in HY31.3.2019.
- PBT was Rs.1.10 Crore in FY2018-19 as against Rs.31.5 Lakh in previous year.
- In the FY2018-19 PAT reached Rs.69.65 Lakh as compared to last year's annual net profit of Rs.2.73 Lakh.

Telengana based Vanta Bioscience Ltd is a full service GLP certified preclinical contract research organization.

Recent Stories